Guidelines

Please note the Scottish Guidance on the use of Immunoglobulin replacement therapy in Hypogammaglobulinaemia secondary to Haematological Malignancies – Jan 2023 is under review and will be available as soon as possible.

Clinical commissioning policy for the use of therapeutic immunoglobulin (Ig) England (2024)

Guidance produced by the Expert Haematology Panel (EHP) focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT) (September 2021)

Guidance produced by the Expert Haematology Panel (EHP) focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT) (September 2021)